When it comes to medical cannabis in the UK, affordability has often been a major concern for patients.

The perception that £5/gram is a good price for cannabis, in general, has persisted, making it challenging for many to access high-quality, medical-grade products. However, the landscape is changing. Lyphe is setting a new standard with a ground-breaking medical cannabis flower range at new affordable price points.

Redefining Affordability

Affordability is not just about finding the lowest price; it’s about ensuring that patients have access to consistent, high-quality products that meet their medical needs. With over 80 medical cannabis flower options in the UK, prices tend to range from £5/gram to £13.75/gram. We hope that the introduction of a less expensive flower is a significant step forward, making medical cannabis more accessible than ever before to the average patient.

Quality You Can Trust

One of the key issues with illicit cannabis is the uncertainty surrounding its quality and origin. Street-bought cannabis often lacks consistency in strain, potency, and purity, posing potential risks to health. In contrast, this new flower offers pharmaceutical-grade cannabis, ensuring that patients receive a product that is safe, reliable, and effective. This high standard of quality control is essential for medical cannabis patients who need a dependable product for their treatment.

Consistency and Reliability

This is not just a temporary promotional product; it’s here to stay. Patients can rely on a consistent price, quality, and supply, making their treatment plans more predictable and stable. This product, a THC 20% dried cannabis flower indica, is designed to meet the therapeutic needs of patients while providing a cost-effective solution.

Legal and Safe

Another major advantage of this product is its legal status. Unlike black-market cannabis, patients obtaining their medicine from a medical cannabis clinic don’t have to worry about legal repercussions or the potential dangers associated with illicit purchases. This peace of mind is invaluable, especially for those who rely on cannabis for medical purposes.

Addressing the Street Price Argument

A common argument from illicit cannabis users is that they can obtain cannabis cheaper on the street without any additional admin or appointment costs. However, this comparison overlooks the numerous risks associated with black-market purchases, including variable quality, unknown strains, and the possibility of contamination. With Lyphe, patients get a high-quality, pharmaceutical-grade product at a price that rivals street prices, eliminating the need to compromise on safety and legality.  

Subject to a medical consultation. The final decision to prescribe a medicine must be made by a qualified healthcare professional in consultation with the patient.

The Future of Affordable Medical Cannabis

The introduction of a more affordable flower is a game-changer for the UK medical cannabis market. By offering a high-quality product at an unprecedented price, Lyphe is making medical cannabis more accessible to those who need it most.

This move not only redefines what affordability means in the medical cannabis sector but also sets a new benchmark for other providers. This is more than just an affordable option; it’s a promise of quality, consistency, and legal assurance.

As Lyphe continues to innovate and lead the way in the medical cannabis industry, patients can look forward to more accessible and reliable treatment options.

If you would like more information on our Noidecs Vital range, click here.